Koninklijke Philips N.V. (NYSE:PHG) Short Interest Update

Koninklijke Philips N.V. (NYSE:PHG) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totaling 2,882,419 shares, an increase of 55.9% from the July 15th total of 1,848,446 shares. Based on an average daily volume of 1,647,504 shares, the short-interest ratio is presently 1.7 days. Approximately 0.3% of the company’s shares are sold short.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PHG. Johnson Financial Group Inc. acquired a new stake in shares of Koninklijke Philips during the 3rd quarter valued at about $27,000. Whipplewood Advisors LLC grew its stake in shares of Koninklijke Philips by 923.7% in the 1st quarter. Whipplewood Advisors LLC now owns 993 shares of the technology company’s stock valued at $27,000 after buying an additional 896 shares in the last quarter. CIBC Private Wealth Group LLC increased its holdings in Koninklijke Philips by 179.6% in the fourth quarter. CIBC Private Wealth Group LLC now owns 1,272 shares of the technology company’s stock worth $34,000 after buying an additional 817 shares during the last quarter. Navalign LLC acquired a new position in Koninklijke Philips in the fourth quarter worth approximately $54,000. Finally, Hilton Head Capital Partners LLC bought a new position in Koninklijke Philips during the fourth quarter valued at approximately $56,000. 13.67% of the stock is owned by institutional investors and hedge funds.

Koninklijke Philips Trading Up 1.1%

Shares of NYSE:PHG opened at $27.10 on Wednesday. The firm has a fifty day moving average of $26.79 and a two-hundred day moving average of $27.70. The company has a quick ratio of 0.82, a current ratio of 1.26 and a debt-to-equity ratio of 0.55. Koninklijke Philips has a 12-month low of $23.85 and a 12-month high of $33.44. The firm has a market capitalization of $26.64 billion, a P/E ratio of 19.97, a price-to-earnings-growth ratio of 11.32 and a beta of 0.76.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Monday, July 27th. The technology company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.17. Koninklijke Philips had a net margin of 6.30% and a return on equity of 14.38%. The business had revenue of $4.98 billion for the quarter, compared to the consensus estimate of $4.91 billion. During the same period in the prior year, the business posted $0.27 earnings per share. Koninklijke Philips’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, equities analysts expect that Koninklijke Philips will post 1.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on PHG shares. UBS Group restated a “neutral” rating on shares of Koninklijke Philips in a report on Monday, August 3rd. Weiss Ratings raised Koninklijke Philips from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. Zacks Research raised Koninklijke Philips from a “strong sell” rating to a “hold” rating in a research note on Thursday, August 13th. Finally, Wall Street Zen upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.